Earnings Feed
Start Free
|4Jul 28, 9:23 PM ET

E&Investment, Inc. 4

4 · NeuroBo Pharmaceuticals, Inc. · Filed Jul 28, 2022

Insider Transaction Report

Form 4
Period: 2022-07-26
NeuroBo Pharmaceuticals, Inc.NRBO
E&Investment, Inc.
10% Owner
Transactions
  • Other

    Common Stock

    2022-07-26−1,445,267→ 2,890,533 total(indirect: Held by The E&Healthcare Investment Fund II)
Holdings

  • Common Stock

    140,147

  • Common Stock

    (indirect: Held by The E&Healthcare Investment Fund No. 6)
    1,121,190

  • Common Stock

    (indirect: Held by The E&Healthcare Investment Fund No. 7)
    1,864,799
Footnotes (6)
  • [F1]E&Healthcare Investment Fund II distributed 1,445,267 shares to its partners on a pro rata basis, for no consideration.
  • [F2]These shares are owned directly by The E&Healthcare Investment Fund II, a 10% owner of the Issuer, and indirectly by its sole general partner, E&Investment, Inc.
  • [F3]E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
  • [F4]E&Investment, Inc. received a pro rata distribution from E&Healthcare Investment Fund II.
  • [F5]These shares are owned directly by The E&Healthcare Investment Fund No. 6, and indirectly by its sole general partner, E&Investment, Inc.
  • [F6]These shares are owned directly by The E&Healthcare Investment Fund No.7, and indirectly by its sole general partner, E&Investment, Inc.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4